Analysis of the antitumor activity of gemcitabine and carboplatin against ovarian clear-cell carcinoma using the DNA damage marker γH2AX

por Takatori, Eriko, Shoji, Tadahiro, Sawai, Takashi, Kurose, Akira, Sugiyama, Toru
Publicado 2013

Are platinum agents, paclitaxel and irinotecan effective for clear cell carcinoma of the ovary? DNA damage detected with γH2AX induced by anticancer agents

por Takatori, Eriko, Shoji, Tadahiro, Kumagai, Seisuke, Sawai, Takashi, Kurose, Akira, Sugiyama, Toru
Publicado 2012

Effective use of everolimus as salvage chemotherapy for ovarian clear cell carcinoma: a case report

por Takatori, Eriko, Shoji, Tadahiro, Miura, Yuki, Takada, Anna, Takeuchi, Satoshi, Sugiyama, Toru
Publicado 2014

A recurrent ovarian cancer patient with a history of nine prior chemotherapy regimens who was safely treated with weekly paclitaxel plus bevacizumab and achieved a complete respons...

por Takatori, Eriko, Shoji, Tadahiro, Nagasawa, Takayuki, Takeuchi, Satoshi, Hosoyachi, Akira, Sugiyama, Toru
Publicado 2015

Clinical Significance of Atypical Glandular Cells in the Bethesda System 2001: A Comparison with the Histopathological Diagnosis of Surgically Resected Specimens

por Shoji, Tadahiro, Takatori, Eriko, Takeuchi, Satoshi, Yoshizaki, Akira, Uesugi, Noriyuki, Sugai, Tamotsu, Sugiyama, Toru
Publicado 2014

A case of ovarian adenosquamous carcinoma arising from endometrioid adenocarcinoma: a case report and systematic review

por Shoji, Tadahiro, Takatori, Eriko, Murakami, Kazuyuki, Kaido, Yoshitaka, Takeuchi, Satoshi, Kikuchi, Akihiko, Sugiyama, Toru
Publicado 2016

Safe administration of bevacizumab combination chemotherapy for the patients with recurrent cervical cancer after pelvic radiotherapy: Two case reports

por Shoji, Tadahiro, Takeshita, Ryosuke, Mukaida, Rika, Takatori, Eriko, Nagasawa, Takayuki, Omi, Hideo, Sugiyama, Toru
Publicado 2018

Neoadjuvant chemotherapy using platinum- and taxane-based regimens for bulky stage Ib2 to IIb non-squamous cell carcinoma of the uterine cervix

por Shoji, Tadahiro, Takatori, Eriko, Saito, Tatsunori, Omi, Hideo, Kagabu, Masahiro, Miura, Fumiharu, Takeuchi, Satoshi, Sugiyama, Toru
Publicado 2012

Expectations and Challenges of First-Line Maintenance Therapy for Advanced Ovarian Cancer

por Shoji, Tadahiro, Sato, Chie, Tomabechi, Hidetoshi, Takatori, Eriko, Kaido, Yoshitaka, Nagasawa, Takayuki, Kagabu, Masahiro, Baba, Tsukasa
Publicado 2021

Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study

por Kagabu, Masahiro, Nagasawa, Takayuki, Tatsuki, Shunsuke, Fukagawa, Yasuko, Tomabechi, Hidetoshi, Takatori, Eriko, Kaido, Yoshitaka, Shoji, Tadahiro, Baba, Tsukasa
Publicado 2021

A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study)

por Nagasawa, Takayuki, Shoji, Tadahiro, Takatori, Eriko, Kaido, Yoshitaka, Kagabu, Masahiro, Shimizu, Dai, Shigeto, Tatsuhiko, Baba, Tsukasa, Sugiyama, Toru, Yokoyama, Yoshihito
Publicado 2023

A retrospective study of neoadjuvant chemotherapy plus radical hysterectomy versus radical hysterectomy alone in patients with stage II cervical squamous cell carcinoma presenting...

por Takatori, Eriko, Shoji, Tadahiro, Takada, Anna, Nagasawa, Takayuki, Omi, Hideo, Kagabu, Masahiro, Honda, Tatsuya, Miura, Fumiharu, Takeuchi, Satoshi, Sugiyama, Toru
Publicado 2016

Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas

por Shoji, Tadahiro, Tatsuki, Shunsuke, Abe, Marina, Tomabechi, Hidetoshi, Takatori, Eriko, Kaido, Yoshitaka, Nagasawa, Takayuki, Kagabu, Masahiro, Baba, Tsukasa, Itamochi, Hiroaki
Publicado 2021

A New Therapeutic Strategy for Recurrent Ovarian Cancer―Bevacizumab beyond Progressive Disease

por Shoji, Tadahiro, Eto, Hisashi, Sato, Takanori, Soma, Rikako, Fukagawa, Daisuke, Tomabechi, Hidetoshi, Takatori, Eriko, Nagasawa, Takayuki, Sato, Seiya, Kagabu, Masahiro, Baba, Tsukasa
Publicado 2019

A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)

por Shoji, Tadahiro, Takatori, Eriko, Kaido, Yoshitaka, Omi, Hideo, Yokoyama, Yoshihito, Mizunuma, Hideki, Kaiho, Michiko, Otsuki, Takeo, Takano, Tadao, Yaegashi, Nobuo, Nishiyama, Hiroshi, Fujimori, Keiya, Sugiyama, Toru
Publicado 2014

Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass

por Shoji, Tadahiro, Takatori, Eriko, Furutake, Yoko, Takada, Anna, Nagasawa, Takayuki, Omi, Hideo, Kagabu, Masahiro, Honda, Tatsuya, Miura, Fumiharu, Takeuchi, Satoshi, Kumagai, Seisuke, Yoshizaki, Akira, Sato, Akira, Sugiyama, Toru
Publicado 2016

A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)

por Shoji, Tadahiro, Takatori, Eriko, Omi, Hideo, Kagabu, Masahiro, Honda, Tatsuya, Futagami, Masayuki, Yokoyama, Yoshihito, Kaiho, Michiko, Tokunaga, Hideki, Otsuki, Takeo, Takano, Tadao, Yaegashi, Nobuo, Kojimahara, Takanobu, Ohta, Tsuyoshi, Nagase, Satoru, Soeda, Shu, Watanebe, Takafumi, Nishiyama, Hiroshi, Sugiyama, Toru
Publicado 2017